DK0977559T3 - Forøget tilførsel af anti-cancer middel til faste tumorer ved primerforbindelser - Google Patents

Forøget tilførsel af anti-cancer middel til faste tumorer ved primerforbindelser

Info

Publication number
DK0977559T3
DK0977559T3 DK98930728T DK98930728T DK0977559T3 DK 0977559 T3 DK0977559 T3 DK 0977559T3 DK 98930728 T DK98930728 T DK 98930728T DK 98930728 T DK98930728 T DK 98930728T DK 0977559 T3 DK0977559 T3 DK 0977559T3
Authority
DK
Denmark
Prior art keywords
solid tumors
agents
primer
agent
camp
Prior art date
Application number
DK98930728T
Other languages
English (en)
Inventor
Kristofer Rubin
Mats Sjoequist
Rolf Reed
Original Assignee
Biophausia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biophausia Ab filed Critical Biophausia Ab
Application granted granted Critical
Publication of DK0977559T3 publication Critical patent/DK0977559T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK98930728T 1997-06-02 1998-05-26 Forøget tilførsel af anti-cancer middel til faste tumorer ved primerforbindelser DK0977559T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702086A SE9702086D0 (sv) 1997-06-02 1997-06-02 Anti-cancer drug delivery to solid tumors
PCT/EP1998/003078 WO1998055112A1 (en) 1997-06-02 1998-05-26 Enhanced anti-cancer agent delivery to solid tumors by primer compounds

Publications (1)

Publication Number Publication Date
DK0977559T3 true DK0977559T3 (da) 2003-01-27

Family

ID=20407206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98930728T DK0977559T3 (da) 1997-06-02 1998-05-26 Forøget tilførsel af anti-cancer middel til faste tumorer ved primerforbindelser

Country Status (12)

Country Link
US (1) US6303660B1 (da)
EP (1) EP0977559B1 (da)
JP (1) JP2002502399A (da)
AT (1) ATE224706T1 (da)
AU (1) AU733882B2 (da)
CA (1) CA2292699A1 (da)
DE (1) DE69808270T2 (da)
DK (1) DK0977559T3 (da)
ES (1) ES2184289T3 (da)
PT (1) PT977559E (da)
SE (1) SE9702086D0 (da)
WO (1) WO1998055112A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630120B1 (en) * 1999-03-08 2003-10-07 Alkermes, Inc. Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
US20030091553A1 (en) * 2001-10-19 2003-05-15 Gehlsen Kurt R. Use of histamine to treat liver disease
JP2011520993A (ja) * 2008-05-27 2011-07-21 オンコリティクス バイオテク，インコーポレーテッド 間質圧力の調節並びに腫瘍崩壊性ウイルスの送達及び分布
JP2015144904A (ja) * 2015-04-20 2015-08-13 佐藤　洋 位置制御システム
KR20190126761A (ko) * 2016-12-22 2019-11-12 마브파마, 인크. Ｉ형 ｉｆｎ 생산을 증강 또는 증대하는 조성물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751224A (en) * 1983-07-21 1988-06-14 Brown University Research Foundation Treatment of metastasis
US4654366A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicyclo[2.2.1]heptane substituted ethers useful as anti-thrombotic agents
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents

Also Published As

Publication number Publication date
ES2184289T3 (es) 2003-04-01
WO1998055112A1 (en) 1998-12-10
DE69808270D1 (de) 2002-10-31
AU733882B2 (en) 2001-05-31
US6303660B1 (en) 2001-10-16
EP0977559A1 (en) 2000-02-09
EP0977559B1 (en) 2002-09-25
DE69808270T2 (de) 2003-05-22
ATE224706T1 (de) 2002-10-15
CA2292699A1 (en) 1998-12-10
PT977559E (pt) 2003-02-28
AU8106198A (en) 1998-12-21
JP2002502399A (ja) 2002-01-22
SE9702086D0 (sv) 1997-06-02

Similar Documents

Publication Publication Date Title
Andersson Erectile physiological and pathophysiological pathways involved in erectile dysfunction
Cunha et al. Parallel modification of adenosine extracellular metabolism and modulatory action in the hippocampus of aged rats
Trendelenburg et al. All three α 2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons
YU76100A (sh) Pirolo(2,3-d) pirimidin preparati i njihova primena
EP1354598A3 (en) Therapeutic uses of BR43X2 soluble receptors
MXPA02004676A (es) Un metodo para quimioprevencion de cancer de prostata.
ATE323088T1 (de) Bicyclische pyridin-und pyrimidinderivate als neuropeptid y rezeptorantagonisten
PT771147E (pt) Composições e métodos para imunidade celular tumoral in vivo melhorada
ID29422A (id) Rakitan elektroda selaput yang lebih baik untuk sel bahan bakar pem
BRPI0418112A (pt) inibidores de p-38 quinase bicìclico heterocìclicos
WO2004050033A3 (en) Method of treating cancers
CA2632433A1 (en) Methods for preparing macrocyclic analogs and intermediates for preparing same
EP1004022A4 (en) METHODS AND COMPOSITIONS FOR OVERCOMING RESISTANCE TO BIOLOGICAL THERAPY AND CHEMOTHERAPY
EP0437103A3 (en) Substituted 5-(alkyl)carboxamide imidazoles
Domin et al. Transport of 5-fluorouracil and uracil into human erythrocytes
IL157841A0 (en) Activation of natural killer cells by adenosine a3 receptor agonists
ATE510553T1 (de) Beta-2-glycoprotein 1 als angiogenesehemmer
BR9803168A (pt) Tratamento de parada cardìaca congestiva.
DK0977559T3 (da) Forøget tilførsel af anti-cancer middel til faste tumorer ved primerforbindelser
WO2001021771A3 (en) Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
EP1064966A3 (en) Combination of an 5HT1 receptor antagonist, caffeine and a cyclooxygenase-2 inhibitor for the treatment of migraine
Ross et al. Modulation by adenine nucleotides of epileptiform activity in the CA3 region of rat hippocampal slices
WO2005011590A3 (en) Compositions and methods for restoring sensitivity to treatment with her2 antagonists
YU77002A (sh) Postupak i preparat za tretiranje kancera putem davanja hemoterapeutskog agensa koji indukuje apoptozis
AU8067198A (en) Compositions for delivery of biological agents and methods for the preparation thereof